Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Sinus Center, Johns Hopkins Medicine, Baltimore, Maryland 21287, USA.
Am J Rhinol Allergy. 2009 Nov-Dec;23(6):562-7. doi: 10.2500/ajra.2009.23.3377.
Rhinosinusitis is a costly disease that adversely affects quality of life (QOL). It is known to be influenced by environmental factors, but few studies have evaluated the association between secondhand tobacco smoke (SHS) exposure and chronic rhinosinusitis (CRS). To address this evidence gap, we evaluated the association of SHS and CRS risk in a community-based case-control study of adult nonsmokers.
In Washington County, MD, 100 cases with a confirmed diagnosis of CRS and 100 controls matched for age, sex, and smoking status (former-never) were recruited and interviewed. A validated questionnaire was used to assess past and present SHS exposure as well as disease-specific QOL.
Compared with those who reported no SHS exposure, current or childhood SHS exposure was associated with significantly increased risk of CRS (odds ratio, 2.33; 95% CI, 1.02, 5.34). CRS cases exposed to SHS (n = 39) had worse mean scores in nasal obstruction/blockage (3.1 versus 2.5; p = 0.02), nasal discharge (3.3 versus 2.7; p = 0.03), headaches (2.4 versus 1.5; p = 0.01), and cough (2.1 versus 1.5; p = 0.04) than cases without SHS exposure (n = 61). Cases exposed to SHS were also more likely to use nasal decongestants (53.9% versus 34.4%; p = 0.05).
Exposure to SHS during childhood and adulthood may be a risk factor for CRS. Furthermore, compared with unexposed CRS cases, SHS exposed cases reported worse nasal symptoms and used more nasal decongestants compared with unexposed cases, suggesting SHS exposure is related to exacerbation and more severe symptoms.
鼻窦炎是一种代价高昂的疾病,会对生活质量(QOL)产生不利影响。已知它受到环境因素的影响,但很少有研究评估二手烟草烟雾(SHS)暴露与慢性鼻窦炎(CRS)之间的关联。为了解决这一证据差距,我们在一项基于社区的成年非吸烟者病例对照研究中评估了 SHS 与 CRS 风险之间的关联。
在马里兰州华盛顿县,招募了 100 例确诊为 CRS 的病例和 100 名年龄、性别和吸烟状况(前吸烟者-从不吸烟者)匹配的对照者,并对他们进行了访谈。使用经过验证的问卷评估过去和现在的 SHS 暴露以及疾病特异性 QOL。
与没有 SHS 暴露的人相比,目前或儿童时期的 SHS 暴露与 CRS 的风险显著增加相关(优势比,2.33;95%置信区间,1.02,5.34)。暴露于 SHS(n = 39)的 CRS 病例的鼻塞/阻塞(3.1 对 2.5;p = 0.02)、鼻分泌物(3.3 对 2.7;p = 0.03)、头痛(2.4 对 1.5;p = 0.01)和咳嗽(2.1 对 1.5;p = 0.04)的平均评分均差于未暴露于 SHS 的病例(n = 61)。暴露于 SHS 的病例也更有可能使用鼻腔减充血剂(53.9%对 34.4%;p = 0.05)。
儿童期和成年期暴露于 SHS 可能是 CRS 的危险因素。此外,与未暴露于 SHS 的 CRS 病例相比,暴露于 SHS 的病例报告的鼻部症状更严重,并且比未暴露于 SHS 的病例使用更多的鼻腔减充血剂,这表明 SHS 暴露与恶化和更严重的症状有关。